Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prodrome Science
Temecula, California, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Prodrome Science offers commercial plasmalogen precursor supplements (ProdromeNEURO, ProdromeGLIA) and the ProdromeSCAN blood diagnostic, based on extensive preclinical and some clinical research showing restoration of plasmalogen levels correlates with improved cognitive and neurological parameters. Published results emphasize safety and biochemical target engagement; broader clinical efficacy for dementia or Alzheimer's is still being established.
- Therapeutic areas
- NeurologyOther
- Modalities
- Small moleculeNutraceuticalBlood test (diagnostic)
- Industry
- Metabolite Diagnostics
Beyond the preview
Go deeper on Prodrome Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prodrome Science.